# Daicel Corporation

Daicel Corporation is an other based in Osaka, Japan.

## Overview

- **Organization type:** other
- **Headquarters:** Osaka, Japan
- **Region:** Asia
- **Address:** Grand Front Osaka Tower B, 3-1 Ofuka-cho, Kita-ku, Osaka, 530-0011, Japan
- **Assets under management:** Undisclosed
- **Website:** daicel.com
- **LinkedIn:** https://www.linkedin.com/company/daicel-corporation

## Regulatory record

- **Reports private funds:** No

## About

100年以上続く「価値共創によって人々を幸せにする会社」株式会社ダイセルの公式サイトです。

## Sectors

- Mobility & Transportation
- Enterprise Software
- Healthcare Services
- Luxury
- Real Estate
- Energy Transition & Renewables

## Offices

- Tokyo, Japan

## Questions

### What is Daicel's core industrial franchise?

Daicel's most durable franchise is the Safety SBU, which designs and manufactures airbag inflators, seatbelt pretensioner gas generators, and current interrupters for the global automotive industry. This unit supplies components embedded in the safety architecture of vehicles produced by nearly every major OEM. The safety systems carry extremely high requalification barriers, creating a structural supply advantage that extends across model cycles.

### How does Daicel participate in the semiconductor supply chain?

Daicel's Smart SBU supplies functional films, photoresist materials, and epoxy compounds used in semiconductor fabrication and printed electronics. These materials fall into performance-critical process steps where purity and formulation consistency determine yields — positioning Daicel as a downstream supplier to chip-manufacturing workflows rather than a semiconductor producer itself.

### What role does cellulose chemistry play in Daicel's current portfolio?

Cellulose chemistry remains Daicel's foundational technology pillar, supporting products such as cellulose acetate for optical films, acetate tow for filtration, and cellulose-derived spherical particles for cosmetics. The firm also runs a marine-degradable cellulose acetate initiative, targeting applications where environmental persistence requirements are tightening, and leverages cellulose-derived materials in pharmaceutical excipients and drug-delivery research.

### Does Daicel operate any life-science or pharmaceutical businesses?

The Life Science SBU produces chiral chromatography columns — the analytical and preparative tools used to separate drug enantiomers in pharmaceutical R&D and production — as well as drug-delivery excipients. Daicel also markets branded consumer-wellness ingredients, including an ingredient derived from Urolithin under the name "Urorich," and operates a contract analytical and separation service for pharmaceutical customers.

### How does Daicel approach carbon reduction and renewable feedstocks?

Daicel has disclosed technology programs for "solar ultra-reduction" targeting carbon-negative chemical production and for dissolving wood pulp without environmental burden. It also markets cellulose acetate as a marine-degradable material and lists biomass value-chain development as an explicit business inquiry category. These programs function as long-horizon R&D tracks connected to existing polymer manufacturing infrastructure, not as offset-based compliance exercises.

## Related profiles

- [Oshkosh Corporation](https://altss.com/profile/oshkosh-corporation)
- [Better Booch](https://altss.com/profile/better-booch)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/daicel-corporation

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology